The YLR149C Antibody (Product Code: CSB-PA314391XA01SVG) is a polyclonal antibody targeting the protein encoded by the YLR149C-A locus in S. cerevisiae. Key specifications include:
| Parameter | Detail |
|---|---|
| Target Protein | YLR149C-A (UniProt ID: P0C5P8) |
| Species Reactivity | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) |
| Size Options | 2 ml or 0.1 ml |
| Applications | Western blotting, immunofluorescence, ELISA (as validated by the manufacturer) |
This antibody is part of a broader catalog of yeast protein-targeting antibodies, with YLR149C-A classified as a protein of unknown function .
While the YLR149C Antibody directly targets YLR149C-A, adjacent genomic loci such as YLR149C (also known as GID11) have been extensively studied. Below are key findings:
GID11/Ylr149c (distinct from YLR149C-A) functions as a substrate receptor in the glucose-induced degradation-deficient (GID) complex, an E3 ubiquitin ligase involved in the Pro/N-degron pathway .
The GID complex targets proteins with N-terminal proline or threonine residues for proteasomal degradation, regulating glucose metabolism and stress responses .
Structural studies show that GID11 recruits substrates to the GID complex via interactions with Gid5 and Gid8, forming a catalytic core .
YLR149C exhibits genetic interactions with YOL038C-A, as shown by synthetic lethality under specific conditions (SGA score: -0.1224, p = 0.033) .
Overexpression of YLR149C-A or related genes may influence plasma membrane electron transport, though mechanistic details remain unclear .
| Application | Sensitivity | Specificity | Validation |
|---|---|---|---|
| Western blotting | High | High | Detects ~25 kDa band in S. cerevisiae lysates . |
| Immunofluorescence | Moderate | Confirmed | Localizes to cytoplasmic puncta . |
YLR149C is a gene in Saccharomyces cerevisiae that has been identified in various gene expression analyses. It appears to be relevant in specific growth conditions as indicated by expression data showing a value of 1.179 in certain experimental contexts . YLR149C has been studied in point mutation experiments and immunoprecipitation assays, suggesting it has functional significance that warrants investigation in yeast models . The protein encoded by this gene serves as a valuable model for understanding fundamental cellular processes in eukaryotes.
Commercial antibodies specifically targeting YLR149C are available for research purposes. For instance, catalog data indicates availability of anti-YLR149C antibodies (product code CSB-PA346887XA01SVG) from suppliers such as Cusabio, specifically designed for Saccharomyces cerevisiae (strain ATCC 204508 / S288c) . These antibodies are typically supplied in volumes of 2ml/0.1ml, making them suitable for multiple experimental applications in academic research settings.
YLR149C antibodies are primarily used in immunoprecipitation (IP) experiments as evidenced by protocols mentioning "PointMutYLR149C_IP" in research databases . These antibodies can be employed in various experimental techniques including:
Western blotting for protein expression analysis
Immunoprecipitation for protein interaction studies
Chromatin immunoprecipitation (ChIP) if YLR149C is associated with chromatin
Immunofluorescence for localization studies
The choice of application depends on the specific research question being addressed regarding YLR149C function.
Based on available gene expression data, YLR149C appears to be differentially expressed under certain growth conditions. While specific values for YLR149C show 1.179 in particular datasets , comprehensive analysis of expression patterns requires consideration of growth phases. For reliable expression analysis, researchers should implement tightly-controlled growth conditions and harvest cells prior to glucose exhaustion, just before the diauxic shift, as demonstrated in membrane protein studies . This timing is critical as yeast metabolism dramatically changes during the transition from glucose to ethanol utilization, potentially affecting YLR149C expression and function.
When conducting immunoprecipitation with YLR149C antibodies, researchers should consider several methodological factors:
Crosslinking protocol: In vivo UV-crosslinking followed by TAP-immunoprecipitation has been successfully used in yeast studies .
Cell preparation: Optimal results require specific growth conditions such as pre-selection on yeast extract with glycerol, followed by controlled growth in dextrose media .
Sample collection timing: For meiotic studies, cells should be isolated from SPO (sporulation) media at specific timepoints .
Control selection: Appropriate controls should include wild-type strains alongside point mutation variants of YLR149C .
These considerations ensure that immunoprecipitation data accurately reflects the in vivo interactions of YLR149C protein.
While direct evidence specifically linking YLR149C to nucleosome positioning is limited in the provided sources, research in yeast has established connections between gene expression and chromatin structure. Nucleosome mapping studies have revealed that certain mutations can affect nucleosome sliding and array formation . Given that YLR149C has been studied in the context of point mutations and immunoprecipitation , investigating its potential role in chromatin structure regulation represents an advanced research direction. Researchers could employ nucleosome repeat length and array regularity calculations to determine if YLR149C mutations affect chromatin architecture.
For robust experimental design when studying YLR149C across different growth conditions:
Growth protocol should follow established methods: Pre-selection on 1% yeast extract, 2% peptone, 3% glycerol, 2% agar for 24 hours at 30°C, followed by growth for 24 hr in 1% yeast extract, 2% peptone, 4% dextrose at 30°C .
For synchronous meiotic studies: Dilute cells in BYTA (1% yeast extract, 2% tryptone, 1% potassium acetate, 50 mM potassium phthalate) to OD600 = 0.2 and grow for 16 hr at 30°C with 300 rpm agitation .
For sporulation conditions: Wash cells with water and re-suspend in SPO (0.3% potassium acetate) at OD600 = 2.0 and incubate at 30°C at 190 rpm .
For ectopic expression: Collect cells after 150 minutes of mitotic growth with 100 μM CuSO4 induction in rich complete synthetic media (2% glucose) .
This systematic approach ensures reproducible growth conditions for meaningful comparison of YLR149C function across different metabolic states.
When analyzing YLR149C expression at the transcriptional level, RNA extraction should follow established protocols:
Use the standard hot acid phenol protocol for yeast RNA extraction .
Specifically, resuspend cell pellets in equal volumes of acid phenol:chloroform for effective extraction .
For quantitative analysis, normalize using reference genes such as ACT1 and PDA1 which maintain relatively stable expression across growth conditions .
For accurate quantification, Real-time Q-PCR can be employed to determine copies of mRNA/cell .
This approach yields high-quality RNA suitable for downstream applications such as RNA-seq or RT-qPCR to analyze YLR149C expression patterns.
To validate YLR149C antibody specificity, researchers should implement a multi-step validation process:
Western blot analysis: Compare wild-type strains with YLR149C deletion mutants to confirm antibody specificity.
Epitope competition assays: Pre-incubate antibodies with purified YLR149C protein or epitope peptides before immunodetection.
Cross-reactivity assessment: Test antibodies against related yeast proteins to ensure specificity.
Immunoprecipitation validation: Verify that immunoprecipitated proteins can be identified as YLR149C by mass spectrometry.
Genetic validation: Use strains with tagged versions of YLR149C to confirm antibody recognition patterns.
These validation steps are critical because antibody specificity directly impacts data interpretation in YLR149C research.
When facing conflicting results with YLR149C antibodies across different experiments:
Compare growth conditions: Strictly control growth phases as protein expression can vary dramatically between glucose and ethanol metabolism phases .
Evaluate antibody compatibility: Different antibody preparations may recognize distinct epitopes, potentially affected by experimental conditions or protein modifications.
Consider strain differences: Compare results between standard laboratory strains (S288c) and other backgrounds (e.g., SK1 for meiotic studies) .
Assess functional redundancy: In yeast, paralogous genes may compensate for each other, masking phenotypes in single mutant studies.
Implement orthogonal methods: Combine antibody-based techniques with genetic approaches (e.g., epitope tagging, deletion analysis) to resolve discrepancies.
This systematic troubleshooting approach helps identify sources of experimental variation affecting YLR149C detection.
For optimal immunoprecipitation of YLR149C:
Cell lysis conditions: Optimize buffer composition to preserve protein-protein interactions while ensuring sufficient extraction.
Antibody concentration: Titrate antibody amounts to determine optimal concentration for specific capture without background.
Bead selection: Compare protein A/G beads with magnetic alternatives to determine highest efficiency.
Washing stringency: Develop a washing protocol that removes non-specific interactions while preserving legitimate binding partners.
Elution methods: Test different elution strategies (competitive elution, pH change, etc.) to maximize recovery.
Each of these parameters should be systematically optimized, as the biochemical properties of YLR149C may require specific conditions for successful immunoprecipitation.
When combining YLR149C antibody techniques with GFP tagging approaches:
Epitope accessibility: Confirm that antibody epitopes remain accessible when YLR149C is GFP-tagged, potentially through western blot validation.
Functional validation: Verify that GFP-tagged YLR149C retains functionality through complementation assays.
Microscopy compatibility: For GFP live-cell microscopy, follow established protocols for yeast and consider fixation methods compatible with subsequent antibody detection.
Dual detection strategies: Design experiments allowing both GFP fluorescence and antibody-based detection without signal interference.
Controls: Include both tagged and untagged strains to assess potential artifacts introduced by tagging.
This integrated approach leverages the strengths of both antibody-based detection and fluorescent protein tagging for comprehensive analysis of YLR149C.
Point mutations in YLR149C can significantly impact antibody recognition and experimental results:
Epitope disruption: Mutations may alter the epitope recognized by the antibody, potentially reducing or eliminating binding.
Protein stability effects: Point mutations can affect protein stability and turnover rates, changing detectable levels independent of expression.
Experimental evidence: Point mutation studies with YLR149C have demonstrated altered patterns in immunoprecipitation experiments , indicating functional changes.
Conformational changes: Even mutations distant from antibody binding sites may induce conformational changes affecting recognition.
Validation approach: For each point mutant, western blot analysis should be conducted to confirm antibody recognition before proceeding with complex experiments.
These considerations are particularly important when studying structure-function relationships in YLR149C.
For robust bioinformatic analysis of YLR149C antibody experimental data:
Demultiplexing, mapping and coverage vector generation for sequencing data .
Composite plot and heatmap generation for visualizing patterns across multiple experiments .
For ChIP-seq or similar applications, nucleosome repeat length and array regularity calculations may be relevant .
Normalization strategies should account for reference genes such as ACT1 and PDA1 that show consistent expression .
Statistical frameworks should incorporate appropriate controls and account for biological variability between replicates.